` STVN (Stevanato Group SpA) vs S&P 500 Comparison - Alpha Spread

STVN
vs
S&P 500

Over the past 12 months, STVN has outperformed S&P 500, delivering a return of +26% compared to the S&P 500's +20% growth.

Stocks Performance
STVN vs S&P 500

Loading
STVN
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
STVN vs S&P 500

Loading
STVN
S&P 500
Difference
www.alphaspread.com

Performance By Year
STVN vs S&P 500

Loading
STVN
S&P 500
Add Stock

Competitors Performance
Stevanato Group SpA vs Peers

S&P 500
STVN
0KHE
TMO
DHR
207940
Add Stock

Stevanato Group SpA
Glance View

Stevanato Group SpA, a stalwart in the realm of pharmaceutical and healthcare solutions, has carved its niche as a pioneering force in precision glass packaging and integrated drug delivery systems. founded in 1949 in Italy, the company ingeniously combines its deep-rooted expertise in glass manufacturing with cutting-edge technology to meet the burgeoning demands of the healthcare and pharmaceutical sectors. Stevanato’s operations are deftly structured around two main segments: the pharmaceutical systems division and the engineering division. Through its pharmaceutical systems division, the company crafts highly specialized glass vials, syringes, and cartridges critical for ensuring the safety and efficacy of drug delivery. These glass containers are not mere vessels but are integral to preserving the integrity of high-value biologic drugs, a prerequisite for gaining regulatory approval and market success. Reaping the benefits of a vertically integrated business model, Stevanato’s engineering division complements its offerings by designing, developing, and manufacturing machinery and technology that optimize the production and inspection of its glass products. This segment caters to pharmaceutical companies' needs for enhanced reliability and efficiency in manufacturing processes, enabling Stevanato to cover the entire value chain from raw material sourcing to final packaging inspection. This seamless integration not only fortifies the company's market position but also ensures a robust revenue stream from both products and services. Stevanato Group's commitment to innovation and quality control, coupled with strategic collaborations, have propelled it as an indispensable partner to global pharmaceutical giants, anchoring its role as both a defender of drug integrity and a trailblazer in medical glassware innovation.

STVN Intrinsic Value
21.72 USD
Overvaluation 13%
Intrinsic Value
Price
Back to Top